Haemonetics Corp. (HAE) Tops Q3 EPS by 3c; Reaffirms Outlook
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $90.87 +0.08%
Financial Fact:
Other income/(expense), net: -1.96M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Other income/(expense), net: -1.96M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Haemonetics Corp. (NYSE: HAE) reported Q3 EPS of $0.50, $0.03 better than the analyst estimate of $0.47. Revenue for the quarter came in at $247.4 million versus the consensus estimate of $251.93 million.
Reaffirmed FY13 and FY14 guidance.
For earnings history and earnings-related data on Haemonetics Corp. (HAE) click here.
Reaffirmed FY13 and FY14 guidance.
For earnings history and earnings-related data on Haemonetics Corp. (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Is Treasury selloff a major issue for stock market bulls?
- Motorsport Games Inc. (MSGM) Tops Q2 EPS by 33c
- L3Harris CEO steps down amid conduct review, shares drop
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
